Vaccelerate is a clinical research network for the coordination and conduct of COVID-19 vaccine trials. The network is comprised of academic institutions from all over Europe. ESI was awarded €200,000 over 3 years (University of Limerick, Pauline Meskell, with University of Galway Linda Biesty, Catherine Houghton and Declan Devane) to lead a Cochrane review titled “Factors that impact on recruitment to vaccine trials during a pandemic or epidemic: a qualitative evidence synthesis” and participate in the Steering group for COVID-NMA and deliver Cochrane reviews titled “Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review” and “Interleukin‐1 blocking agents for treating COVID‐19″
This funded project supports the activities of the EU/EEA National Immunisation Technical Advisory Groups’ (NITAGs) in their decision-making on national vaccination programmes, including COVID-19 vaccines.
The consortium includes Cochrane Germany, Cochrane Austria, Cochrane Ireland, the Robert Kock Insitut and PWC.
Cochrane Ireland, through the University of Galway, was awarded €410,000 over 4 years to lead on (q) four evidence syntheses in the area of vaccines and/or EU/EEA vaccination programmes, and (b) developing and delivering an online training program on methodologies for assessing evidence and carrying out reviews, synthesis and evaluations and subsequent transformation into technical documents/guidance.